Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 04, 2014 08:30 ET | Source: Biocept, Inc.

Biocept to Present at Upcoming Investor Conferences

SAN DIEGO, Sept. 4, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA)...
September 03, 2014 08:30 ET | Source: Biocept, Inc.

Biocept Strengthens Its Circulating Tumor Cell IP Position in Europe

SAN DIEGO, Sept. 3, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA)...
August 14, 2014 08:30 ET | Source: Biocept, Inc.

Biocept Provides Second Quarter Operational Update

SAN DIEGO, Aug. 14, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in Circulating Tumor Cells (CTCs) and Circulating Tumor DNA (ctDNA)...
August 06, 2014 08:30 ET | Source: Biocept, Inc.

Biocept Appoints Managed Care Expert to Lead Contract and Reimbursement Strategy

SAN DIEGO, Aug. 6, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in Circulating Tumor Cells (CTCs) and Circulating Tumor DNA (ctDNA)...
June 02, 2014 08:30 ET | Source: Biocept, Inc.

Biocept Expands Breast Cancer Offering

Blood-based OncoCEE-BR™ Platform now Includes Estrogen Receptor Testing SAN DIEGO, June 2, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company...
May 19, 2014 07:00 ET | Source: Biocept, Inc.

Biocept Announces National Sales Force

SAN DIEGO, May 19, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of cell-free circulating tumor DNA and Circulating...
May 07, 2014 16:15 ET | Source: Biocept, Inc.

Biocept, Inc. Closes $10 Million Term Loan Facility With Oxford Finance LLC

SAN DIEGO, May 7, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular diagnostics company specializing in oncology biomarker detection and monitoring through circulating tumor cells...
April 28, 2014 08:30 ET | Source: Biocept, Inc.

Biocept Launches Clinical Research Services for Biomarker Detection in Circulating Tumor DNA

SAN DIEGO, April 28, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular diagnostics company specializing in oncology biomarker detection and monitoring through circulating tumor cells...
March 24, 2014 11:04 ET | Source: Biocept, Inc.

Biocept Appoints Commercialization Leader to Implement Global Diagnostic Sales Program

SAN DIEGO, March 24, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in Circulating Tumor Cells (CTCs), Circulating Tumor DNA (ctDNA) and...
March 05, 2014 08:30 ET | Source: Biocept, Inc.

Biocept, Inc. to Present at the 26th Annual ROTH Conference

SAN DIEGO, March 5, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), an oncology diagnostics company focused on improving individual patient treatment, announced today that the Company's...